双水平气道正压通气治疗肺尘埃沉着病并肺心病的短期效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (30 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the short-term effect of bi-level positive airway pressure (BiPAP) in the treatment of pneumoconiosis with pulmonary heart disease.Methods A total of 60 patients with pneumoconiosis and pulmonary heart disease who were admitted to Lianhua County People′s Hospital from July 2019 to March 2020 were selected as the research objects,and they were divided into the observation group (30 cases) and the control group (30 cases) according to the random number table method.The control group was treated with meglumine cyclic adenosine monophosphate,and the observation group was given BiPAP on the basis of conventional treatment in the control group.The total effective rate and clinical indicators of the two groups were compared.Results The total effective rate of treatment in the observation group was higher than that in the control group,and the difference was statistically significant (P＜0.05).After treatment,the oxygenation index of the observation group was higher than that of the control group,the degree of lower limb edema and the content of arterial blood carbon dioxide were lower than that of the control group,and the hospitalization time of the observation group was shorter than that of the control group,the differences were statistically significant (P＜0.05).Conclusion BiPAP has a significant short-term effect in the treatment of pneumoconiosis with pulmonary heart disease,which can improve the symptoms and heart and lung functions of patients and is worthy of promotion.

Key words： Bi-level positive airway pressure Pneumoconiosis Pulmonary heart disease Meglumine Cyclic Adenosine

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Yi-xin
	WU Zheng-yi
	JIA Jin-hu

Cite this article:

ZHANG Yi-xin,WU Zheng-yi,JIA Jin-hu. Short-term effect of bi-level positive airway pressure in the treatment of pneumoconiosis with pulmonary heart disease[J]. 中国当代医药, 2021, 28(6): 48-50.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I6/48

[1]	李卫东.复方丹参注射液联合参麦注射液治疗肺心病的临床疗效[J].中西医结合心脑血管病杂志，2017，15（23）：1567-1568.
[2]	杨柳.补肺正气汤与穴位贴敷联合常规疗法治疗肺气亏虚型肺心病临床研究[J].国际中医中药杂志，2017，39（9）：794-797.
[3]	李雪峰.丹参川芎嗪联合NIPPV 对老年肺心病患者心肺功能及血清sST2、NT-proBNP 的影响[J].河北医药，2019，41（11）：1614-1617，1622.
[4]	中华预防医学会劳动卫生与职业病分会职业性肺部疾病学组.肺尘埃沉着病病治疗中国专家共识（2018年版）[J].环境与职业医学，2018，35（8）：677-689.
[5]	杨媛华.慢性肺源性心脏病的识别与诊断[J].中华全科医师杂志，2019，18（9）：900-901.
[6]	中华医学会，中华医学会杂志社，中华医学会全科医学分会，等.慢性肺源性心脏病基层诊疗指南（2018年）[J].中华全科医师杂志，2018，17（12）：959-965.
[7]	高杨，李杰，王增智，等.支气管扩张症合并慢性肺源性心脏病临床特点分析[J].心肺血管病杂志，2019，38（1）：26-29，39.
[8]	王春芳，于耀龙，赵富栋.孟鲁司特钠联合双水平气道正压通气呼吸机治疗哮喘-慢性阻塞性肺疾病重叠综合征的效果[J].中国临床实用医学，2018，9（4）：25-29.
[9]	陈亮，张建红，张莹莹，等.支气管镜灌洗治疗老年煤工肺尘埃沉着病合并肺炎疗效观察[J].中国工业医学杂志，2018，31（3）：182-183.
[10]	Torres MF，Porfírio GJ，Carvalho AP，et al.Non-invasive positive pressure ventilation for prevention of complications after pulmonary resection in lung cancer patients[J].Cochrane Database Syst Rev，2019，3（3）：CD010355.
[11]	丁兆勇，王新凤，杨爱珍，等.双水平气道正压通气在重症肺炎合并急性呼吸衰竭治疗中的应用价值[J].中国实用医刊，2018，45（12）：31-33.
[15]	周莲萍.双水平气道正压通气疗法治疗慢性阻塞性肺疾病、冠心病合并呼吸衰竭的疗效探析[J].当代医药论丛，2019，15（13）：1328-1329.
[12]	Cai WW，Hu J，Wang H，et al.I-level positive airway pressure ventilation for patients with hypoxemia after coronary artery bypass grafting[J].J Biol Regul Homeost Agents，2019，33（2）：403-408.
[13]	Guan LL，Wu WL，Huo YT，et al.Efficacy of bilevel positive airway pressure and continuous positive airway pressure therapy in patients with obesity hypoventilation syndrome：protocol for systematic review and meta-analysis[J].BMJ Open，2018，8（5）：e020832.
[14]	Nehme J，LaBerge R，Pothos M，et al.Treatment and persistence/recurrence of sleep-disordered breathing in children with Down syndrome[J].Pediatr Pulmonol，2019，54（8）：1291-1296.